Two China biotechs drop U.S. IPO plans for $800 mln Hong Kong floats -sources
April 26, 2018 at 01:05 AM EDT
* Ascentage picks Hong Kong over U.S. due to new HKEX rules -chief
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.